iShares Neuroscience and Healthcare ETF Rating $39.14 +0.04 (+0.10%) As of 08/14/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.82Holdings in IBRN have an aggregate rating of Moderate Buy based on 358 analyst ratings issued in the past year covering 21 companies (74.6% of the portfolio).IBRN Aggregate Price Target$39.14High Prediction$39.14Average Prediction$39.14Low Prediction$39.14Holdings in IBRN have an aggregate price target of $39.14 and a range of $39.14 to $39.14 covering 21 companies (74.6% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 IBRN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.55%PRAXPraxis Precision Medicines$366.81-0.4%3.2382 of 5 stars3.00$573.05 56.2%22Analyst Revision5.20%DNTHDianthus Therapeutics$115.96+5.8%1.9189 of 5 stars2.93$124.27 7.2%14Insider Trade4.89%ACADACADIA Pharmaceuticals$28.24-0.5%4.5468 of 5 stars2.82$33.69 19.3%17Analyst Forecast4.76%XENEXenon Pharmaceuticals$62.35-2.9%3.0045 of 5 stars3.00$77.13 23.7%17Insider TradeAnalyst RevisionGap Down4.53%SRRKScholar Rock$52.52-1.0%1.7399 of 5 stars3.12$57.71 9.9%17News CoverageAnalyst ForecastAnalyst Revision4.47%ARWRArrowhead Pharmaceuticals$86.64+1.2%1.9584 of 5 stars2.62$97.33 12.3%134.31%ALKSAlkermes$49.06-0.8%3.1617 of 5 stars2.72$54.56 11.2%18Positive News4.02%BIIBBiogen$209.83-0.4%3.9844 of 5 stars2.58$227.07 8.2%33Analyst Downgrade3.81%PTCTPTC Therapeutics$71.70-0.4%3.661 of 5 stars2.64$98.55 37.4%14Analyst Forecast3.74%DNLIDenali Therapeutics$24.40-1.7%2.9049 of 5 stars2.75$35.92 47.2%16News CoverageAnalyst Revision3.74%ARGXargenex$851.29-0.7%4.7555 of 5 stars2.92$1,056.89 24.2%24Positive News3.71%NBIXNeurocrine Biosciences$152.72+1.3%4.9877 of 5 stars2.88$200.86 31.5%24Analyst Downgrade3.54%EWTXEdgewise Therapeutics$44.17+2.3%2.0292 of 5 stars2.82$49.08 11.1%11Trending NewsAnalyst ForecastInsider Trade3.47%DYNDyne Therapeutics$25.70-1.0%3.7419 of 5 stars2.87$34.42 33.9%15Positive News3.45%AXSMAxsome Therapeutics$213.670.0%3.3113 of 5 stars2.82$267.60 25.2%22Earnings ReportAnalyst Forecast2.59%SUPNSupernus Pharmaceuticals$48.27+2.4%4.2516 of 5 stars2.71$62.83 30.2%72.33%AXGNAxoGen$48.73+1.4%2.4851 of 5 stars2.73$51.00 4.7%11Insider Trade1.84%BHVNBiohaven$14.66-1.3%3.5017 of 5 stars2.65$21.75 48.3%17Earnings ReportAnalyst Forecast1.73%SRPTSarepta Therapeutics$18.10-1.7%3.7639 of 5 stars2.20$25.06 38.4%20Analyst Upgrade1.53%TSHATaysha Gene Therapies$5.95-0.7%2.6161 of 5 stars3.00$12.77 114.6%14News CoverageEarnings Report1.34%RAPPRapport Therapeutics$47.42+0.1%3.4942 of 5 stars2.92$61.57 29.8%12Analyst ForecastInsider TradeAnalyst Revision This page (NYSEARCA:IBRN) was last updated on 8/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
